A survey on the prevalence of orofacial herpes in France: The INSTANT Study - 09/08/11
Tours, Marly le Roi, Bourg la Reine, Créteil, and Nantes, France
Abstract |
Orofacial herpes is a common benign disease suspected to significantly impact the quality of life (QOL) of affected subjects. The objective of this population-based study was to evaluate the annual prevalence of orofacial herpes in France, its epidemiology, and its impact on QOL. Face-to-face home interviews were conducted among a random sample of 10,263 adults. A screening questionnaire identified subjects with a history of orofacial herpes (or cold sore) during the past 12 months; then, subjects with herpes completed another questionnaire to further describe their disorder and its management, and the SF-36 questionnaire to assess their QOL. The annual prevalence of orofacial herpes was 14.8% (95% confidence interval 14.03; 15.47); it was significantly higher in women than in men (P < .001) and decreased with age (P < .001). Among subjects with herpes, only 23% were aware of their disease. Tiredness and emotional stress were the main triggering events. There was no detectable difference between subjects with herpes and controls on SF-36 scores; however, when compared with subjects with 1 to 5 episodes per year, subjects with 6 or more episodes per year had significantly lower QOL scores.
Le texte complet de cet article est disponible en PDF.Abbreviations used : CI, HSV, INSEE, QOL
Plan
Supported by GlaxoSmithKline. Disclosure: Drs Lorette, Wolkenstein, and Stalder have received remuneration from GlaxoSmithKline for their participation in the study and article elaboration. Dr Mimaud is employed by the service supplier that has contracted with GlaxoSmithKline. Drs Crochard and El Hasnaoui are employees of GlaxoSmithKline. |
Vol 55 - N° 2
P. 225-232 - août 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?